Identification of targeted analyte clusters for studies of schizophrenia

Tammy M.K. Cheng, Yu En Lu, Paul C. Guest, Hassan Rahmoune, Laura W. Harris, Lan Wang, Dan Ma, Victoria Stelzhammer, Yagnesh Umrania, Matt T. Wayland, Pietro Lió, Sabine Bahn*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The search for biomarkers to diagnose psychiatric disorders such as schizophrenia has been underway for decades. Many molecular profiling studies in this field have focused on identifying individual marker signals that show significant differences in expression between patients and the normal population. However, signals for multiple analyte combinations that exhibit patterned behaviors have been less exploited. Here, we present a novel approach for identifying biomarkers of schizophrenia using expression of serum analytes from first onset, drug-naïve patients and normal controls. The strength of patterned signals was amplified by analyzing data in reproducing kernel spaces. This resulted in the identification of small sets of analytes referred to as targeted clusters that have discriminative power specifically for schizophrenia in both human and rat models. These clusters were associated with specific molecular signaling pathways and less strongly related to other neuropsychiatric disorders such as major depressive disorder and bipolar disorder. These results shed new light concerning how complex neuropsychiatric diseases behave at the pathway level and demonstrate the power of this approach in identification of disease-specific biomarkers and potential novel therapeutic strategies.

Original languageEnglish
Pages (from-to)510-522
Number of pages13
JournalMolecular and Cellular Proteomics
Issue number3
Publication statusPublished - Mar 2010

Bibliographical note

© 2010 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.. Creative Commons Attribution (CC BY 4.0)


Dive into the research topics of 'Identification of targeted analyte clusters for studies of schizophrenia'. Together they form a unique fingerprint.

Cite this